China Universal Asset Management Co., Ltd. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 298 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2024$216,557
-32.7%
12,642
-38.6%
0.03%
-24.4%
Q1 2024$321,665
+74.3%
20,580
+66.5%
0.04%
+13.9%
Q4 2023$184,580
+317.3%
12,363
+351.4%
0.04%
+176.9%
Q3 2023$44,235
-23.4%
2,739
+96.8%
0.01%
-27.8%
Q2 2023$57,768
-32.8%
1,392
-2.6%
0.02%
-37.9%
Q1 2023$85,940
+9.9%
1,429
+34.1%
0.03%
-6.5%
Q4 2022$78,191
+4.3%
1,066
+8.7%
0.03%
-3.1%
Q3 2022$75,0009810.03%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
StepStone Group LP 1,365,479$29,767,00021.90%
Tamarack Advisers, LP 1,115,000$24,307,00011.56%
COURAGE CAPITAL MANAGEMENT LLC 275,000$5,995,0004.57%
GREAT POINT PARTNERS LLC 753,481$16,426,000,0002.44%
HARTLINE INVESTMENT CORP/ 404,052$8,808,0002.42%
Pier Capital, LLC 346,350$7,550,0001.29%
Rhenman & Partners Asset Management AB 435,000$9,483,0001.17%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,029,910$22,452,0000.77%
PEREGRINE CAPITAL MANAGEMENT LLC 922,468$20,110,0000.49%
Hodges Capital Management Inc. 285,500$6,224,0000.49%
View complete list of NOVOCURE LTD shareholders